Serum Institute Developed Quadrivalent Human Papillomavirus Vaccine For Cervical Cancer Patients 9 To 26 Years
The Drugs Controller General of India’s (DCGI) Subject Expert Committee (SEC) has recommended the quadrivalent human papillomavirus (qHPV) vaccine developed ...
